The following section deals with manufacturing technologies of Pharmaceuticals and up-to-date pharmaceutical equipment
Celltrion (South Korea) signed an ‘Incubation’ agreement with Emory University (Atlanta, USA) to support the research and development of new drug candidates for atherosclerosis.
Molecular Templates and Takeda announced an agreement for the joint development of CD38-targeted engineered toxin bodies (ETBs) for the treatment of patients with diseases such as multiple myeloma.
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions , announced a commercial supply agreement with Aucta Pharmaceuticals.
Sosei (Japan) and Allergan (USA) have been forced to call a halt to testing of a drug for Alzheimer’s disease and other forms of dementia after cancer was seen in non-human primate studies. The dru...
Compugen, an Israeli clinical-stage cancer immunotherapy and predictive target discovery company, has earned a $7.8 million milestone payment from German pharma giant Bayer.
Propanc Biopharma, an Australian clinical stage biopharmaceutical company focusing on development of new and proprietary treatments for cancer patients suffering from solid tumors (pancreatic, ovarian...
Funding to support Artificial Intelligence (AI) in drug discovery takes a significant step forward as the Medicines Discovery Catapult secured a grant from Innovate UK to fund a €1,26 million project.
The Skolkovo has teamed up with Bayer to launch a competition to help biotech startups advance their projects and secure their intellectual property rights.